Chris Rizik, investor at Renaissance Venture Capital, on building in-house platforms and company-creation in biopharma. D.A. Wallach, general partner at Time BioVentures, praises a founder’s rapid responsiveness and focus. Casber Wang, investor at Sapphire Ventures, recounts Kyle Hanselman’s evolution scaling SMB cybersecurity through MSP distribution and team reshuffles. They focus on visionary leadership, platform leverage, founder adaptability, and market timing.
